Back to Search
Start Over
Catheter Ablation of Low-Voltage Areas for Persistent Atrial Fibrillation: Procedural Outcomes Using High-Density Voltage Mapping
- Source :
- Canadian Journal of Cardiology. 36:1956-1964
- Publication Year :
- 2020
- Publisher :
- Elsevier BV, 2020.
-
Abstract
- Several approaches have been proposed to address the challenge of catheter ablation of persistent atrial fibrillation (AF). However, the optimal ablation strategy is unknown. We sought to evaluate the efficacy of pulmonary vein isolation (PVI) plus low-voltage area (LVA) ablation using contemporary high-density mapping to identify LVA in patients with persistent AF.Consecutive patients accepted for AF catheter ablation were studied. High-density bipolar voltage mapping data were acquired in sinus rhythm using multipolar catheters to detect LVA (defined as bipolar voltage0.5 mV). Semiautomated impedance-based software was used to ensure catheter contact during data collection. Patients underwent PVI + LVA ablation (if LVA present).A total of 145 patients were studied; 95 patients undergoing PVI + LVA ablation were compared with 50 controls treated with PVI only. Average age was 61 ± 10 years, and 80% were male. Baseline characteristics were comparable. Freedom from atrial tachycardia/AF at 18 months was 72% after PVI + LVA ablation vs 58% in controls (P = 0.022). Median procedure duration (273 [240, 342] vs 305 [262, 360] minutes; P = 0.019) and radiofrequency delivery (50 [43, 63] vs 55 [35, 68] minutes; P = 0.39) were longer in the PVI + LVA ablation group. Multivariable analysis showed that the ablation strategy (PVI + LVA) was the only independent predictor of freedom from atrial tachycardia/AF (hazard ratio, 0.53; 95% confidence interval, 0.29-0.96; P = 0.036). There were no adverse safety outcomes associated with LVA ablation.An individualized strategy of high-density mapping to assess the atrial substrate followed by PVI combined with LVA ablation is associated with improved outcomes. Adequately powered randomized clinical trials are needed to determine the role of PVI + LVA ablation for persistent AF.
- Subjects :
- Male
Canada
medicine.medical_specialty
medicine.medical_treatment
Catheter ablation
030204 cardiovascular system & hematology
Pulmonary vein
law.invention
03 medical and health sciences
0302 clinical medicine
Randomized controlled trial
Heart Conduction System
Recurrence
law
Internal medicine
Atrial Fibrillation
Secondary Prevention
medicine
Humans
Sinus rhythm
Diagnosis, Computer-Assisted
030212 general & internal medicine
Atrial tachycardia
business.industry
Hazard ratio
Middle Aged
Ablation
Confidence interval
Outcome and Process Assessment, Health Care
Treatment Outcome
Pulmonary Veins
Catheter Ablation
Cardiology
Female
medicine.symptom
Electrophysiologic Techniques, Cardiac
Cardiology and Cardiovascular Medicine
business
Subjects
Details
- ISSN :
- 0828282X
- Volume :
- 36
- Database :
- OpenAIRE
- Journal :
- Canadian Journal of Cardiology
- Accession number :
- edsair.doi.dedup.....f6ad10ebd5a3d923c6a90edca4945d82
- Full Text :
- https://doi.org/10.1016/j.cjca.2020.03.040